Issues in Oncology

Immediate Patient Access to Test Results and the Impact on Advanced Practitioners

By Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO

Editor-in-Chief Beth Faiman considers how the immediate release of electronic health information to patients can lead to challenges for advanced practitioners, who are expected to quickly review results and address expectations.

How Do We Achieve Value-Based, Patient-Centered Care?

By Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO

Editor-in-Chief Beth Faiman describes the hallmarks of patient-centered care delivery and strategies for advanced practitioners to achieve value-based, patient-centered care.

Artificial Intelligence: How Is it Relevant to Advanced Practitioners?

By Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO

We have all seen artificial intelligence (AI) being increasingly integrated into our daily lives, from how we communicate with others to the way we shop and manage our information. There are emerging examples of applications in health ca...

Use of the 31-Gene Expression Profile Test to Aid in the Decision of Adjuvant Treatment of Cutaneous Melanoma

By Jillian Hunt, MSN, APRN, FNP-C, AOCNP

Melanoma is the fifth most common cancer in the United States, with over 7,000 deaths annually. Although most patients diagnosed with early-stage (stage I or II) disease have an excellent prognosis, two out of three patients who die from...

Staying Abreast of New Biomarkers in Hematology/Oncology

Presented by Andrew Guinigundo,(1) MSN, RN, CNP, ANP-BC, FAPO, and Grace Baek,(2) PharmD, BCOP

There has been an increasing number of approvals for targeted therapies in oncology in the past decade, changing the treatment paradigm for many solid tumors and hematologic malignancies. At JADPRO Live 2023, presenters provided an in-de...

Shaping the Future of Oncology at JADPRO Live 2023

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO

Last fall, the 2023 JADPRO Live conference welcomed more than 1,500 in-person attendees and 200 virtual attendees. Sessions took place at the Orlando World Center Marriott from November 9 through 12. Select CE-accredited sessions were li...

The Ethics of Genetic Testing for Inherited Cancer-Predisposing Genes

Steven Sorscher,(1) MD, and Alisha T. DeTroye,(2) MMS, PA-C, DFAAPA

Once an individual has been identified as a carrier of an inherited cancer-predisposing gene or pathogenic germline variant (PGV), there are measures that have been proven to prevent and diagnose the associated cancers at an earlier, mor...

Risk Factors for Immune Checkpoint Inhibitor–Related Myocarditis: An Integrative Review

Sara M. Otto, MS, APRN, FNP-BC, AOCNP®, Ashely L. Martinez, DNP, APRN, FNP-BC, AOCNP®, CBCN, CPHQ, NEA-BC, and Joyce E. Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP, FAAN

Purpose: The purpose of this integrative literature review was to determine factors that increase the risk of immune checkpoint inhibitor (ICI)–related myocarditis in the cancer patient population. Methods: A literature review was conduc...

Burnout in Advanced Practitioners and the Benefit of Protected Time

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO

Today, I learned an interesting fact. There is a diagnosis code to classify what many of us currently struggle with: burnout. The International Statistical Classification of Diseases and Related Health Problems (ICD-10) has a classificat...

A Comprehensive Bone Marrow Aspirate and Biopsy Educational Program Utilizing Task Trainers

Jessica Casselberry, DNP, ANP-BC, AOCNP®, and Jennifer Fisher, DNP, WHNP

Background: Advanced practice providers (APPs) who care for patients with hematologic malignancies perform bone marrow aspiration and biopsies (BMBXs). Invasive bedside procedures are often taught through the observational training metho...

The Cost of Care: Financial and Social Factors in Cancer Management

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO

A Financial Toxicity Screening and Care Coordination Quality Improvement Program in a Gynecology Oncology Urban Practice

Tina Harris,(1) DNP, NP-C, AOCNP®, Julie Brinzo,(1) DNP, APRN, MBA, FNP-C, and Christopher Pell,(2) PhD

Background: Educating a multidisciplinary team on financial toxicity (FT) risk, screening, and care coordination is an approach to addressing gaps in care among newly diagnosed patients with stage III or IV cancer. Objective: The goal of...

Clinical Posters From JADPRO Live 2023

Thirty-three clinical posters focused on the role of the advanced practitioner were presented at JADPRO Live this past November 9 to 12, 2023, in Orlando, Florida. Read the abstracts here, and access the full posters and audio narrations...

Clinical Utility of the 31-Gene Expression Profile Test on the Management of Cutaneous Melanoma by Nurse Practitioners and Physician Assistants

By Renata Block, MMS, PA-C, Deborah Patterson, MMS, PA-C, Jennifer J. Siegel, PhD, Brian Martin, PhD, Ann P. Quick, PhD, Jillian Hunt, MSN, APRN, FNP-C, AOCNP

Objective: The 31-gene expression profile (31-GEP) can predict the risk of recurrence and metastasis in cutaneous melanoma (CM). We assessed the viewpoints and use of 31-GEP testing by physician assistants (PAs) and nurse practitioners (...

When Germline Genetic Testing Results Are Unclear: Highlighting Variants of Uncertain Significance

Patricia Kelly,(1) DNP, APRN, CNS, AGN-BC, AOCN®, Suzanne Mahon,(2) DNS, RN, AOCN®, AGN-BC, FAAN, and Patricia Friend,(3) PhD, APRN-CNS, AOCNS®, AGN-BC

With the advent of high-throughput next-generation sequencing (NGS) and multigene panel testing, genetic testing and interpretations have become increasingly complex. Specifically, reports demonstrating “variant of uncertain significance...

Mitigating Burnout: Transition to a Condensed Workweek for Advanced Practice Providers in Infectious Diseases

Shannon Holloway, PA-C, Kelly McConn, Pa-C, Roy Borchardt, PA-C, PhD, Victor E. Mulanovich, MD, and Javier A. Adachi, MD

Burnout among health-care workers is highly prevalent and profoundly impacts the quality of patient care. In addition to affecting patient safety, burnout results in higher staff turnover, revenue deficits due to decreased productivity, ...

Pancreatic Cancer and the Family Connection: The Role of Advanced Practitioners in Screening and Educating Genetically At-Risk Individuals

Tracy Lowe,(1) PhD, MS, RN, Jane DeLuca,(1) PhD, MS, RN, CPNP-PC, Ludovico Abenavoli,(2) MD, PhD, MSc, and Luigi Boccuto,(1) MD

Pancreatic cancer is the third leading cause of cancer deaths in the United States. It has a 95% mortality rate within 5 years of the initial diagnosis. Pancreatic ductal adenocarcinoma is the most commonly diagnosed histotype. The avera...

The Importance of Endpoints in Oncology Clinical Trials

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO

Innovative clinical trials identify appropriate endpoints when seeking to evaluate potential new cancer treatments, better ways of using existing medications, or enhanced supportive care techniques. A recent X (formerly Twitter) post hig...

Providing Care During Cancer Drug Shortages

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO

Drug shortages have become a global phenomenon, reaching an all-time high and affecting nearly every therapeutic area of medicine. Even short-term drug shortages cause deleterious effects in critical populations such as our patients with...

Rethinking Medical Aid in Dying: What Does It Mean to ‘Do No Harm?’

Dallas R. Lawry, DNP, FNP-C, AOCNP®

Medical aid in dying is the act of prescribing lethal medications to a consenting patient who can self-ingest them with the intent of hastening their death. A majority of patients who utilize medical aid in dying are patients with termin...

Value Assessment of Oncology Pharmacist Interventions

Mallika P. Patel, PharmD, CPP, Sally Y. Barbour, PharmD, BCOP, CPP, FHOPA, and Meredith T. Moorman, PharmD, BCOP, CPP

A review of the published literature confirms the challenge in quantifying the value of oncology pharmacists. This editorial expands on a 2020 study by Meleis and colleagues published in the Journal of the Advanced Practitioner in Oncolo...

Tips for Writing a Research Protocol

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO

A brilliant advanced practitioner colleague, whose article you will find in this issue, asked whether JADPRO would publish her successfully funded grant application. When I asked about her motivation to become a researcher and seek grant...

What Does Dobbs v. Jackson Mean for Oncology Patients and Providers? Current Considerations for Pregnancy and Fertility in the Oncology Setting

Presented by Brianna Hoffner,(1) MSN, ANP-BC, AOCNP®, FAPO, Leslie C. Appiah,(2) MD, Alexis C. Geppner,(3) MLS, CTTS, MPAS, PA-C, Laxmi A. Kondapalli,(4) MD, MSCE, and Govind Persad,(5) JD, PhD

The incidence of cancers such as colorectal cancer, head and neck cancer, and melanoma has increased in younger patients. The number of cancer survivors is also increasing in the US. Pairing these facts together, there are many people wi...

Uncovering and Addressing Implicit Bias in Oncology

Presented by Rose DiMarco,(1) PharmD, BCPS, BCOP, Andrew S. Guinigundo,(2) MSN, RN, CNP, ANP-BC, and Caressa Valdueza,(3) MSN, AGNP-C

Implicit bias affects patient care every day, and not just in oncology. It impacts decision-making in already vulnerable populations such as the historically marginalized racial and ethnic groups, the LGBTQI+ population, patients with di...

Medical Aid in Dying: Ethical and Practical Issues

Presented by Jonathan Treem, MD

At JADPRO Live 2022, Jonathan Treem, MD, of the University of Colorado Palliative Care, explained medical aid in dying in order to prepare advanced practitioners to feel confident to counsel a patient who inquiries about aid in dying. He...

JADPRO Live 2022: Reaching the Peak of Practice

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO

This special issue of JADPRO includes summaries of select educational sessions presented at JADPRO Live 2022. 

The Importance of Professional Communities and Collaborations

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO

The complexity of cancer care requires unique skill sets that must be cultivated. Collaborating with professionals specializing in different areas ensures comprehensive and patient-centered care. A multidisciplinary approach can lead to ...

Oncology Advanced Practice Posters: New Research and Insights Into Our Future

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO

Presenting a poster at a conference is an important way for us as advanced practitioners to showcase our work, receive feedback, and affect future directions in the way we care for our patients. Conversely, as an attendee, I am always in...

Serious Illness Conversation Training for Inpatient Medical Oncology Advanced Practice Providers: A Quality Improvement Project

Jo Clarke, DNP, ANP-BC, NP-C, ACNP-BC, APRN-CNP, AOCNP®, Mary Alice Momeyer, DNP, APRN-CNP, Robin Rosselet, DNP, RN, APRN-CNP, AOCN®, Loraine Sinnott, PhD, and Janine Overcash, PhD, APRN-CNP, FAANP, FAAN

Background: Hospitalized advanced cancer patients and their families are inadequately informed about their cancer diagnosis and prognosis, which limits educated and reasonable decision-making for their care and end-of-life planning. Obje...

Interventions to Improve Advanced Practitioner Work-Related Quality of Life and Patient Satisfaction

Heather Jackson, PhD, FNP-BC, NEA-BC, FAANP, Olivia West, MSN, AG-ACNP-BC, Annie Austin, MSN, AGACNP-BC, AOCNP®, and Karline Peal, MBA, RTT

Background: Across the United States, an incremental need for cancer care continues to emerge. Specialty nurse practitioners and physician assistant teams have helped in meeting this demand. However, there is a need for evidence-based re...

Clinical Posters From JADPRO Live 2022

Thirty-six clinical posters focused on the role of the advanced practitioner were presented at JADPRO Live this past October 20 to 23, 2022, in Aurora, Colorado. View the poster listing here, and access the abstracts, posters, and audio ...

Supporting Advanced Practice Fellowship During COVID-19

Miranda Osborne,(1) MSN, RN-BC, CEN®, Amy Rettig,(2) DNP, MALM, APRN-BC, Amy Lindsey,(2) MS, APRN-CNS, PMHCNS-BC, Kris Mathey,(2) MS, APRN-CNP, AOCNP®, Loraine Sinnott,(3) PhD, and Diana McMahon,(2) DNP, MSN, RN, OCN®

With the aging population and increasing number of cancer survivors contributing to a projected provider shortage, one solution is the specialization of nurse practitioners and physician assistants (part of the advanced practice provider...

Inclusion of Racial and Ethnic Minorities in Cancer Clinical Trials: 30 Years After the NIH Revitalization Act, Where Are We?

Faith Mutale, DNP, CRNP

The lack of diversity in cancer trials is a multifaceted, decades-old problem that has remained persistent despite efforts to increase the number of participants from underrepresented racial and ethnic backgrounds. This lack of meaningfu...

JADPRO Live 2022: Reaching the Peak of Practice

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO

The 2022 JADPRO Live conference was held in person from October 20 to 23 in Aurora, Colorado. I was excited to finally see peers I had only met virtually throughout these past 2 years. Numerous advanced practitioner–designed sessions on ...

The Role of Echocardiogram and Cardiac Rhythm Analysis for Early Detection of Cardiac Amyloidosis

Elizabeth Hubert, APRN, FNP-C, and Joyce E. Dains, DrPH, JD, APRN, FNP-BC, FNAP, FAANP

Purpose: The purpose of this integrative review was to establish the role of cardiac rhythm analysis (electrocardiogram; EKG) and echocardiogram in increasing clinical suspicion for and earlier diagnosis of cardiac amyloidosis. Methods: ...

Timely Genetic Testing and Therapy Management in Patients With gBRCA-Mutated Metastatic Breast Cancer Receiving Talazoparib

Ashley Martinez,(1) DNP, APRN, FNP-BC, AOCNP®, CBCN, CPHQ, NEA-BC, Tiffany Jones,(2) MSN, ACNP-BC, Joanne C. Ryan,(3) PhD, RN, Chad M. Barnett,(3) PharmD, BCOP, Elpitha L. Soussou,(3) PharmD, MBA, and Sarah Donahue,(4) MPH, NP, AOCNP®

Talazoparib is a poly(ADP-ribose) polymerase (PARP) inhibitor that has demonstrated strong efficacy with manageable side effects for patients with germline breast cancer susceptibility genes 1 or 2 (gBRCA1/2)-mutated, human epidermal gro...

The Impact of an Embedded Oncology Pharmacist in an Outpatient Oncology Center in the Treatment of Hematologic Malignancies

Denisse Mae Trinidad, PharmD, and Puja R. Patel, PharmD, BCOP

Background: The growing demand for clinicians in the ambulatory oncology setting to reduce fragmentation of care and improve patient outcomes represents a need for oncology pharmacists as advanced practitioners in the provision of direct...

Development of a Standardized Bone Marrow Procedure Training and Competency Toolkit for Advanced Practice Providers in a Large Community Oncology Practice

Katharine Lord,(1) PA-C, Sara Toth,(2) APRN, FNP-C, AOCNP®, AGN-BC, Jennifer Potter,(3) PA-C, Katherine Sellers,(4) PA-C, Monica White,(5) APRN, CNS-AH, ACNP-BC, AOCNP®, Anne Neugent,(4) APRN, FNP-C, and Tracy Martin,(4) APRN, ANP-C, AOCNP®, BMTCN, NursEd

Bone marrow procedures are a common diagnostic tool utilized in hematology/oncology and can be completed in the office by trained clinicians. Currently, there are limited guidelines for appropriate training and competency for bone marrow...

Management of Adverse Events in Early Clinical Trials by Advanced Practice Providers in the Outpatient Setting: The University of Texas MD Anderson Cancer Center Experience

Fedricker D. Barber (1), Erick Campbell (1), Yuko Yamamura (1), Clover J. Patterson (1), Audrey C. Hartnett (1), Holly Kinahan (1), Victoria A. Miller (1), Amanda L. Brink (1), Anna Poullard (1), Gabriele E. Urschel (1), Andre Brantley (1), Isabel G. Cepeda (1), Poonam Goswami (1), Sheena Charles (1), Shincy Philip (1), Sara Bresser (1), Sandra Musekiwa-Adjei (1), Nageli Perez (1), Hung Le (1), Penny Phillips (2), Vivek Subbiah (1), Funda Meric-Bernstam (1,3,4), and Ecaterina E. Dumbrava (1)

Background: Advanced practice providers (APPs) play important roles in enrolling, educating, and caring for patients in clinical trials. However, much remains unknown about the role of APPs in managing adverse events (AEs) in early (phas...

Insights Into the Publishing Process

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO

Writing for publication allows one to share ideas, thoughts, research, and practice patterns. A valuable tool to disseminate various types of information, peer-reviewed articles contribute to the body of literature and collective knowled...

The AP Role in Clinical Research: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner

Elizabeth Koselke, PharmD, BCOP and Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP®

Elizabeth Koselke, PharmD, BCOP, of The US Oncology Network, describes a clinical pharmacist intervention to screen patients and improve clinical trial enrollment. Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP®, of the University of Haw...

Hematologic Malignancies: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner

P. Andrew Allred, MS, PA-C, Amy Pierre, MSN, ANP-BC, Meredith Beaton, MSN, RN, Pamela Lee, NP, MSN, and Amber Koehler, PA-C

P. Andrew Allred, MS, PA-C, of Banner MD Anderson Cancer Center, considers data on managing newly diagnosed MM and CAR T-cell therapy in MM. Amy Pierre, MSN, ANP-BC, of MSKCC and Flatiron Health, reviews findings on telemedicine inequiti...

2022 ASCO Annual Meeting: Takeaways for the Advanced Practitioner

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN

Welcome to our special issue on highlights from the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting. Taking place from June 3 to 7, 2022, oncology professionals from around the world convened in Chicago to discuss the la...

Complexities of Care and the Interdisciplinary Team

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN

Many of you who are reading this article are advanced practitioners (APs) and experts in the management of complex patient symptoms. Despite managing “side effects” of treatment for years as a nurse, then an advanced practitioner, I did ...

Measuring Advanced Practice Provider Productivity at the National Comprehensive Cancer Network’s Member Institutions

Diana Krause(1), Karen Sharrah(2), Anne Gross(3), Danielle Bowers(3), Daniel Mulkerin(4), Nancy Brandt(4), Kate Kennedy(5), Annie Austin(5), Aaron Begue(6), Rose Bell(7), Cheryl Raczyk(7), Todd Pickard(8), Timothy Kubal(9), Dave Johnson(9), Kellyann Jeffries(10), Vanna Dest(11), Rory Randall(12), Jessica Sugalski(1), and Gabrielle Zecha(13)

Introduction: The utilization of advanced practice providers (APPs) in oncology has been growing over the last decade; however, there is no standard method for assessing an APP’s contributions to oncology care. Methods: The NCCN Best Pra...

COVID-19 Vaccine Effectiveness in Oncology Patients

Rachel La Costa, MPAS, PA-C

Oncology patients are at greater risk of morbidity and mortality from coronavirus disease 2019 (COVID-19) infection than the general population. Patients with malignancies were prioritized in vaccine distribution to confer protection to ...

Practical Strategies for Advanced Practitioners Streamlining the Integration of Oncology Biosimilar Therapies Into Practice

Kelley D. Mayden,(1) DNP, APRN-FNP, AOCNP®, John M. Kelton,(2) PharmD, Joanne C. Ryan,(2) PhD, RN, and Ali McBride,(3,4) PharmD, BCPS, BCOP

In oncology practices across the United States, biosimilars—highly similar versions of licensed, innovator (reference) biological medicines—are currently emerging as more affordable therapeutic options. Only after a rigorous product deve...

Do You Employ Shared Decision-Making in Your Practice?

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, FAAN

Editor-in-Chief Beth Faiman discusses how shared decision-making is an important component of any patient-centered encounter, and reviews a tool to help advanced practitioners incorporate these strategies into visits.

Cardio-Oncology Considerations in Oncologic Treatment Decisions

Anecita P. Fadol, PhD, FNP-BC, FAANP, FAAN

At JADPRO Live Virtual 2021, presenter Anecita P. Fadol, PhD, FNP-BC, FAANP, FAAN, emphasized the critical role advanced practitioners play in the identification, monitoring, and management of the cardiac complications of cancer therapy....

The Advanced Practice Role in Clinical Trials: Past, Present, and Future

Colleen Lewis, MSN, ANP-BC, AOCNP®

At JADPRO Live Virtual 2021, Colleen Lewis, MSN, ANP-BC, AOCNP®, discussed the trajectory of the advanced practitioner role in clinical research, including the historical experience, potential barriers to practice, and future possibiliti...

Positive Practice Changes After the COVID-19 Pandemic: From the Advanced Practice Provider Perspective

R. Donald Harvey,(1) PharmD, BCOP, FCCP, FHOPA, Aaron Begue,(2) MS, RN, NP-C, Caleb Raine,(1) PA-C, and Robin Yabroff,(3) PhD, MBA

At the opening session of JADPRO Live Virtual 2021, panelists shared creative responses to the COVID-19 pandemic and considered strategies to effectively respond to crises that may impact cancer patients and practices in the future.

Pull Up a Seat: Engaging Patients as Empowered Partners in Health Equity Transformation

by Maimah Karmo,(1) and Amy Pierre,(2),(3) MSN, ANP-BC

At the JADPRO Live Virtual 2021 keynote interview, Maimah Karmo, CEO and Founder of the Tigerlily Foundation, spoke with Amy Pierre, MSN, ANP-BC, on her breast cancer experience and drive to establish an organization that educates, advoc...

A Call to Action: The Role of the Oncology AP in Equitable Cancer Care

Brianna Hoffner,(1) MSN, ANP-BC, AOCNP®, Josh Epworth,(2) ARNP, Beth Faiman,(3) PhD, MSN, APRN-BC, AOCN®, FAAN, and Soumya J. Niranjan,(4) BPharm, MS, PhD

The COVID-19 pandemic has only further brought to light how racism, bias, and lack of equity can result in social injustice, morbidity, and mortality. A panel of four advanced practitioners convened at JADPRO Live Virtual 2021 to examine...

Race, Social Determinants of Health, and Cancer: How Can APs Address and Improve Patient Outcomes?

Rose DiMarco,(1) PharmD, BCPS, BCOP, and Lisania Milli,(2) MSN, RN, WHNP-BC

The data show that racial and ethnic minority groups throughout the United States experience higher rates of illness and death across a wide range of health conditions when compared to their White counterparts. This session at JADPRO Liv...

JADPRO Live Virtual 2021: New Paths to Patient Care

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, FAAN

This special issue of JADPRO includes summaries of educational sessions presented at JADPRO Live Virtual 2021.

Identifying the Leader in You

Elisabeth King,(1) FNP-C, and Sara Toth,(2) FNP-C

The leadership journey is often a long and winding road, with speed bumps and unexpected turns. During this session of JADPRO Live Virtual, presenters discussed the leadership qualities that they have found integral, including emotional ...

Thriving, Not Just Surviving: Recognizing Burnout and Simple Tips to Start Feeling Better

Margaret Leddy, PA-C, MMSc

Burnout has been prevalent since before COVID-19 and continues to affect a large portion of the health-care workforce. At JADPRO Live Virtual 2021, Margaret Leddy, PA-C, MMSc, defined burnout in the setting of the oncology/hematology adv...

Multidisciplinary Tumor Boards and Guiding Patient Care: The AP Role

Joan Okasako,(1) MSN, FNP-BC, RN, AOCNP®, and Carolyn Bernstein,(2) MSN, FNP-BC, RN

The history of multidisciplinary tumor boards extends to more than 50 years ago. At JADPRO Live Virtual 2021, presenters discussed the evidence-based impact of tumor boards on patient outcomes and patient-centered care, reviewed benefits...

Cardiovascular Adverse Events and Mitigation Strategies for Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor Therapy

Lisa Nodzon, PhD, APRN, AOCNP®, Anecita Fadol, PhD, FNP-BC, FAANP, FAAN, and Sara Tinsley, PhD, APRN, AOCN®

Cardiovascular (CV) risk mitigation is an important consideration in the management of chronic myeloid leukemia (CML) patients. Although BCR-ABL1 inhibition by tyrosine kinase inhibitors (TKI) has led to a significant improvement in prog...

Role of Oncology Advanced Practitioners to Enhance Clinical Research

Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP®, Leigh M. Boehmer, PharmD, BCOP, Laura J. Zitella, MS, RN, ACNP-BC, AOCN®, Brianna Hoffner, MSN, ANP-BC, AOCNP®, Yurii B. Shvetsov, PhD, Jeffrey L. Berenberg, MD, Randall A. Oyer, MD, and Al B. Benson III, MD

Background: Oncology advanced practitioners (APs), including nurse practitioners, clinical nurse specialists, physician assistants, and clinical pharmacists contribute significantly to quality cancer care. Advanced practitioners enhance ...

How to Succeed as an Advanced Practitioner in a Multifaceted Role

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, FAAN

Nearly 20 years ago, I was one of the first in an advanced practitioner (AP) role in the outpatient area of a major academic institution. There was one other AP at the time I was hired, so I asked to shadow her for a day. I could see tha...

General and Unique Communication Skills Challenges for Advanced Practice Providers: A Mixed-Methods Study

Deborah Stein,(1) ACNP-BC, Kerry Cannity,(2) PhD, Richard Weiner,(1) NP, Shira Hichenberg,(1) Angelina Leon-Nastasi,(1) Smita Banerjee,(1) PhD, and Patricia Parker,(1) PhD

Aims: Advanced practice providers are a rapidly growing sector of the health-care field. Despite their relatively new place in the medical establishment, these providers are held to high standards of education, practice, and communicatio...

Assessment of Oncology Provider Knowledge and Cardiovascular Screening Practices: A Call for Heightened Screening

Katherine Albert,(1) DNP, FNP-BC, AOCNP®, Deborah Pollard,(1) PhD, RNC-OB, CNE, IBCLC, Jennifer Klemp,(2) PhD, MPH, MA, Lavanya Kondapalli,(3) MD, and Deborah Tuffield,(1) DNP, FNP-C, CCRN

Cardiac risk factors are known to compound the development of cardiotoxicities (CTx) in patients exposed to anthracycline (ANT) chemotherapy agents. National oncology and cardiology organizations have published recommendations for cardio...

Improving Health Equity: The Role of the Oncology Advanced Practitioner in Managing Implicit Bias

Kelley D. Mayden, MSN, FNP, AOCNP®, IAC

Implicit bias (IB) is the involuntary activation of thoughts, feelings, attitudes, or stereotypes that exist outside of conscious awareness. Implicit bias develops early in life and research documents the existence of IB across health-ca...

JADPRO Live Virtual 2021

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, FAAN

Editor-in-Chief Beth Faiman takes a look back at memorable moments from the ninth annual JADPRO Live conference, which took place virtually in early October.

Abstracts From JADPRO Live 2021

VIRTUAL • OCTOBER 7–17The posters for the abstracts below can be found at JADPROLive.com

Current Testing Guidelines: A Retrospective Analysis of a Community-Based Hereditary Cancer Program

Margaret Ward,(1) DNP, APRN, AGN-BC, Betty Elder,(2) PhD, RN, and Maryon Habtemariam,(2) DNP, APRN

It is estimated that 5% to 10% of all cancers are related to a hereditary cancer syndrome. However, specific cancers, such as pancreatic and ovarian cancers, are related to hereditary cancer syndromes 15% to 20% of the time. Genetic test...

Advanced Practitioners as Allies and Advocates

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, FAAN

Advanced practitioners (APs) are a growing proportion of the health-care team. As of 2019, there were approximately 325,000 nurse practitioners, 7,000 clinical nurse specialists, and nearly 140,000 physician assistants in the United Stat...

On Becoming an Ally

Josh Epworth, ARNP

Earlier this year, I was asked to participate in a meeting titled “Virtual Summit to Define the Role of Oncology Advanced Practitioners in Equitable Cancer Care Delivery: A Closer Look at Care Coordination, Clinical Trials, and Implicit ...

A Study of Advanced Practice Provider Staffing Models and Professional Development Opportunities at National Comprehensive Cancer Network Member Institutions

Annie Austin,(1) Kellyann Jeffries,(2) Diana Krause,(3) Jessica Sugalski,(3) Karen Sharrah,(4) Anne Gross,(5) Danielle Bowers,(5) Daniel Mulkerin,(6) Nancy Brandt,(6) Aaron Begue,(7) Rose Bell,(8) Cheryl Raczyk,(8) Todd Pickard,(9) David Johnson,(10) Vanna Dest,(11) Rory Randall,(12) Gabrielle Zecha,(13) and Kate Kennedy,(1)

Introduction: The National Comprehensive Cancer Network (NCCN) Best Practices Committee created an Advanced Practice Provider (APP) Workgroup to develop recommendations to support APP roles at NCCN Member Institutions. Methods: The Workg...

Issues in Oncology: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner

Josh Epworth, ARNP

Josh Epworth, ARNP, of University of Washington Medical Center, considers the findings of three important abstracts from the 2021 ASCO Annual Meeting and reflects on how advanced practitioners can improve access and care for their patien...

Disparities and Access to Care: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner

Amy Pierre, MSN, ANP-BC

Amy Pierre, MSN, ANP-BC, of Flatiron Health and Memorial Sloan Kettering Cancer Center, considers takeaways from a program targeting minority accrual to oncology trials and a study evaluating minority representation in precision oncology...

Publish or Perish

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, FAAN

In the past 10 years, APs have become more engaged in clinical research and publishing articles of interest for their peers. In fact, in 2019, there was a 24% increase in the number of submissions to JADPRO compared with the first year t...

Understanding Attitudes and Roles of Oncology Advanced Practitioners in the Setting of Cancer Clinical Trials: A Pilot Study

Christa Braun-Inglis,(1,2) MS, APRN-Rx, FNP-BC, AOCNP®, Yurii B. Shvetsov,(2) PhD, Ashley Springer,(3) MSN, APRN-Rx, AGPCNP-BC, Valerie Ferguson,(4) MSN, APRN-Rx, FNP-C, AOCNP®, Tyler Workman,(5) MS, APRN-Rx, AGPCNS-BC, Dee Ann Omatsu,(6) MS, APRN-Rx, PNP-BC, CPON, Francisco Conde,(7) PhD, APRN-Rx, AOCNP®, FAAN, Erin O’Carroll Bantum,(2) PhD, and Jessica Rhee,(2) MD

Purpose: Oncology advanced practitioners (APs), including nurse practitioners, physician assistants, clinical nurse specialists, and pharmacists, are skilled health-care providers who contribute significantly to quality cancer care. Howe...

Quality Improvement Projects and Clinical Research Studies

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, FAAN

Editor-in-Chief Beth Faiman celebrates the contributions of advanced practitioners in quality improvement projects and clinical research studies, and compares the characteristics of each type of study.

Mitigating the Morbidity of Financial Toxicity in Cancer Care

Presented by Veena Shankaran, MD, MS

At JADPRO Live Virtual 2020, Veena Shankaran, MD, MS, reviewed data around the prevalence and risk factors for financial toxicity, discussed potential downstream consequences of financial toxicity in cancer care, and outlined four key st...

Cardio-Oncology: The Intersection Between Cardiovascular Disease and Cancer

Presented by Jessica Shank Coviello, DNP, APRN, ANP-BC, and Kejal Amin, PharmD, MBA, BCOP

Cardio-oncology is a rapidly emerging field, and advanced practitioners (APs) play key roles in the prevention, early detection, and optimal treatment of cardiotoxicities associated with cancer therapies. At JADPRO Live Virtual 2020, Jes...

Words Matter: Use of Respectful Language in Oncology

Presented by Laura J. Zitella,(1) MS, RN, ACNP-BC, AOCN®, and Tatiana M. Prowell,(2) MD

During JADPRO Live Virtual 2020, Conference Chair Laura J. Zitella, MS, RN, ACNP-BC, AOCN®, spoke with Tatiana M. Prowell, MD, about overcoming implicit bias, the power of language, and creating a culture of respect in oncology for both ...

JADPRO Live Virtual 2020: Learning Today, Leading Tomorrow

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, FAAN

In this special issue of JADPRO, we highlight important takeaways for advanced practitioners from the educational sessions presented at our annual meeting, JADPRO Live.  

Advanced Practitioner Leadership in Times of Crisis

Presented by Gabrielle Zecha,(1) PA-C, MHA, Andrew S. Guinigundo,(2) MSN, RN, CNP, ANP-BC, David Johnson,(3) PA-C, and Sara Toth,(4) RN, APRN, FNP-C, AOCNP®, AGN-BC

JADPRO Live Virtual kicked off with the opening panel on advanced practitioner leadership during the COVID-19 pandemic. The group discussed their institutional emergency protocols, how they leveraged advanced practitioners (APs) to provi...

Are Current Metrics Adequate to Demonstrate the Value of Oncology Advanced Practitioners?

Presented by Jason Astrin, DMSc, MBA, PA-C, DFAAPA

At JADPRO Live Virtual 2020, Jason Astrin, DMSc, MBA, PA-C, DFAAPA, defined the concepts of productivity and value and discussed strategies for measuring the value of oncology advanced practitioners in order to recognize advanced practit...

The Elevator Pitch: Communicating Your Expertise, Experience, and Value to Patients, Co-Workers, and Prospective Employers in an Instant

Presented by Andrew S. Guinigundo, MSN, RN, CNP, ANP-BC

During JADPRO Live Virtual 2020, Andrew S. Guinigundo, MSN, RN, CNP, ANP-BC, provided guidance to advanced practitioners on creating their elevator pitch and communicating their role. 

A Role to Alleviate Burnout and Maintain Quality of Care

Jessica Zucker, RN, MSN, AGNP-BC, Glen J. Peterson, RN, DNP, ACNP, Angela Falco, RN, MS, MPH, FNP-C, and Jessica Casselberry, RN, MSN, ANP-BC, AOCNP®

Health care in acute care settings has become increasingly complex and stressful with rapidly evolving treatment options, a growing aging population with multiple comorbidities, and expectations to deliver high-quality care with less res...

A Case of Unintentional Nonadherence

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, FAAN

Editor-in-Chief Beth Faiman reflects on the pivotal role of advanced practitioners in addressing both intentional and unintentional nonadherence with patients.

Evaluation of the Role and Impact of Ambulatory Clinical Pharmacists in an Academic Comprehensive Cancer Center

Laura A. Meleis, PharmD, MS, BCPS, Mallika P. Patel, PharmD, CPP, Michael DeCoske, PharmD, BCPS, Meredith Moorman, PharmD, CPP, Paul W. Bush, PharmD, MBA, BCPS, FASHP, and Sally Barbour, PharmD, BCOP, CPP, FHOPA

Introduction: In recent years, there has been significant growth of ambulatory oncology pharmacy, yet there is a paucity of published studies on the clinical activities and impact of ambulatory oncology clinical pharmacists. At Duke Canc...

Clinical Trial Design and Drug Approval in Oncology: A Primer for the Advanced Practitioner in Oncology

Sandra E. Kurtin,(1) PhD, ANP-C, AOCN®, and Rashida Taher,(2) MPH, PA-C

Evidenced-based practice requires timely and accurate integration of scientific advances. This presents a challenge for the oncology clinician given the robust pace of scientific discovery and the increasing number of new drug approvals ...

The Changing Landscape of Healthcare and Continuing Education

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, FAAN

Issues in Oncology: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner

Josh Epworth, ARNP

Josh Epworth, ARNP, of Seattle Cancer Care Alliance/University of Washington Medical Center, distills three influential abstracts from the ASCO virtual meeting and reflects on how advanced practitioners can use the findings to improve th...

ASCO20 Virtual Scientific Program: Takeaways for the Advanced Practitioner

Beth Faiman, PhD, MSN, APRN-BC, AOCN®, FAAN

Phase 1 Clinical Trials in the Elderly: Enrollment Challenges

Carol Guarnieri, RN, MSN, FNP-C, and Daniel D. Von Hoff, MD, FACP, FASCO, FAACR

Cancer mostly affects older adults. Despite the increased incidence of cancer among older adults, they are underrepresented in oncology clinical trials. Such trials can provide patients with early access to promising interventions. Clini...

Perceptions of Health-Care Workers of the Cost and Safety of Oral Oncolytic Agents for Patients: A Survey

Madeline Tompkinson,(1) PharmD, Kelly Fine,(2) RPh, FAzPA, Dean Gruber,(3) RPh, Ivo Abraham,(4) PhD, RN, and Ali McBride,(5) PharmD, MS, BCPA, BCOP

Purpose: The number of newly approved cancer medications continues to grow; many of these newly approved medications are oral agents. Oral oncolytic agents have advantages including patient convenience, prolonged drug exposure, and nonin...

Mayo Clinic Hematology Fellowship for Advanced Practice Providers

Yi L. Hwa,(1) DNP, APRN, CNP, Jessica L. Shelly,(1) MSN, APRN, Darci L. Zblewski,(1) MSN, APRN, Megan T. Spychalla,(1) PA-C, Dawn M. Udenberg,(1) DNP, APRN, Kathryn R. Cieslak,(2) MS, Grzegorz S. Nowakowski,(1) MD, Martha Q. Lacy,(1) MD, and Ariela L. Marshall,(1,3) MD

Advanced practice providers (APPs), including nurse practitioners (NPs) and physician assistants (PAs), are part of a growing cancer care workforce. Current hematology-specific education provided by most graduate NP and PA school educati...

Development of a Hematology-Oncology Advanced Practice Provider Fellowship Program

Jenna A. Kramer, ACNP-BC, and Camille Petraitis Valente, DNP, FNP-BC

New graduate advanced practice providers (APPs) who accept jobs within the hematology-oncology field face many challenges when beginning their careers. Specific challenges include a lack of specialty-specific training, expedited orientat...

Burnout, Workplace Factors, and Intent to Leave Among Hematology/Oncology Nurse Practitioners

Laura Bourdeanu,(1) NP, PhD, Qiuping (Pearl) Zhou,(2) PhD, RN, Michelle DeSamper,(3) Kaitlin Anne Pericak,(4) MA, and Arlene Pericak,(2) FNP-BC, DA

Background: Burnout and intent to leave have been well documented in oncology/hematology health-care professionals, with a potentially detrimental effect on the patient-provider relationship and job satisfaction. With the recommended cha...

Determination of the Fair Market Value of Oncology Advanced Practitioners

Wendy H. Vogel, MSN, FNP, AOCNP®

It is essential for the advanced practitioner to have an understanding of how fair market value is determined by employers in order to successfully negotiate a compensation package or salary raise. However, because of the compliance and ...

Patient Safety and Disclosure

Pamela Hallquist Viale, RN, MS, CNS, ANP

The Development of an Oncology Clinical Nurse Specialist Fellowship Program

Allison Ann de Villiers,(1) MSN, APRN-CNS, OCN®, ACNS-BC, Lisa Maree Blackburn,(1) MS, APRN-CNS, RN-BC, AOCNS®, Danette Birkhimer,(1) MS, APRN-CNS, AOCNS®, Lynne R. Brophy,(1) MSN, APRN-CNS, RN-BC, AOCN®, Jamie Tippett,(1) MS, RN, NEA-BC, Karen Meade,(1) MS, APRN-CNS, AGCNS-BC, CPAN®, OCN®, and Carlton G. Brown,(2) PhD, RN, AOCN®, NEA-BC, FAAN

New graduate clinical nurse specialists (CNSs) face many challenges when starting their new role. To address this, a CNS fellowship program was developed to mentor new CNSs during their first year of practice. This CNS fellowship program...

Advanced Practitioners: Collaborators in Radiation Oncology

P. Andrew Allred,(1) MS, PA-C, Maura N. Polansky,(2) MS, MHPE, PA-C, Kathryn Doerksen,(3) MSPAS, PA-C, and Steven H. Wei,(4) MS, MPH, PA-C

Advanced practitioners (APs), including physician assistants (PAs) and nurse practitioners (NPs), are medical professionals with advanced training, degrees, and certifications that qualify them to diagnose and treat medical conditions in...

2019 ASCO Annual Meeting Highlights for the Advanced Practitioner: Issues in Oncology

Pamela Hallquist Viale, RN, MS, CNS, ANP

Several abstracts presented at the ASCO Annual Meeting reflected the meeting theme of providing high-quality care to every patient. Following coverage by The ASCO Post, Editor-in-Chief to JADPRO, Pamela Hallquist Viale, RN, MS, CNS, ANP,...

2019 ASCO Annual Meeting: Takeaways for Advanced Practitioners

Pamela Hallquist Viale, RN, MS, CNS, ANP

Editor-in-Chief Pamela Hallquist Viale, RN, MS, CNS, ANP, introduces the first JADPRO issue offering coverage of the most important research presented at the ASCO Annual Meeting.

Cardiac Toxicity and Anthracyclines: Mechanism, Interventions, and the Trouble With Troponin

Grace E. Thompson, MSN, AGACNP-BC, AGPCNP-BC, and Phyllis P. Wright, DNP, AGPCNP-BC, MPH

As cancer survivorship increases, clinicians need to become educated regarding the long-term effect of cancer treatments. Cancer therapeutics–related cardiac dysfunction (CTRCD) is one such sequela that contributes to significant morbidi...

Secondary Analysis Research

Rita J. Wickham, PhD, RN, AOCN®

Abstract In secondary data analysis (SDA) studies, investigators use data collected by other researchers to address different questions. Like primary data researchers, SDA investigators must be knowledgeable about their research area to...

Diversity Awareness and Documentation Practices Among Oncology Advanced Practice Providers

Victoria Poillucci, MSN, ACNP-BC, and Christina Z. Page, MSN, RN, AOCNP®, AGPCNP-BC

Abstract Advanced practice providers (APPs) care for widely diverse populations. The Institute of Medicine (IOM) states that bias, prejudice, and stereotyping by a health-care provider may contribute to disparities, which are associated...

JADPRO Live 2018: Bringing Clarity to Complexity

Pamela Hallquist Viale, RN, MS, CNS, ANP

In this special issue to JADPRO, we showcase the main features of educational sessions from our annual meeting.

Evidence-Based Oncology Practice: Competencies for Improved Patient Outcomes

Kelley D. Mayden, MSN, FNP, AOCNP®, IAC

Abstract Oncology advanced practice providers (APP) play a critical role in providing cancer care to patients and families. Given the rate of scientific advancement, APPs are challenged to keep with the pace of science and acquire tools...

The Stepped-Wedge Trial Design: Paving the Way for Cancer Care Delivery Research

Ya-Huei Li, PhD, Elizabeth Mullette, RN, MSN, and Jeannine M. Brant, PhD, APRN, AOCN®, FAAN

Abstract Cancer care delivery research (CCDR) is an emerging field that investigates ways to optimally provide care for patients within complex health-care systems. Novel research designs are essential to efficiently study CCDR research...

Understanding the Role of Advanced Practice Providers in Oncology in the United States

Suanna S. Bruinooge,(1) Todd A. Pickard,(2),(3) Wendy Vogel,(4) Amy Hanley,(1) Caroline Schenkel,(1) Elizabeth Garrett-Mayer,(1) Eric Tetzlaff,(5) Margaret Rosenzweig,(6) Heather Hylton,(7) Shannon N. Westin,(3) Noël Smith,(2) Conor Lynch,(8) Michael P. Kosty,(9) and Stephanie F. Williams(10)

Abstract Purpose: Advanced practice providers (APPs, which include nurse practitioners [NPs] and physician assistants [PAs]) are integral members of oncology teams. This study aims first to identify all oncology APPs and, second, to und...

Do the Right Study: Quality Improvement Projects and Human Subject Research—Both Valuable, Simply Different

Theresa Wicklin Gillespie, PhD, MA, RN

Presenting With Confidence

Wendy H. Vogel, MSN, FNP, AOCNP®, and Pamela Hallquist Viale, RN, MS, CNS, ANP

Abstract Often, advanced practitioners must give clinical presentations. Public speaking, which is a major fear for most individuals, is a developed skill. Giving an oral presentation is a good way to demonstrate work, knowledge base, a...

Cardio-oncology: A Subspecialty in its Infancy

Cardiovascular and Cancer Risk: The Role of Cardio-oncology

Abstract Cardio-oncology is a subspecialty of cardiology. It was created to address oncology data indicating that newly developed drugs for cancer treatment were having unanticipated cardiac side effects. Cardio-oncology designs primary...

Joining Forces: Establishing a Cardio-oncology Clinic

Abstract Patients have been surviving cancer diagnoses at a steadily increasing rate over the past few decades. Despite the encouraging decline in cancer morbidity, the cardiovascular effect of some chemotherapy medications is concernin...

Multigene Panel Testing for Hereditary Cancer Risk

The Challenges of Clinical Research in Rare Cancers: Bevacizumab Use in Low-Grade Serous Ovarian and Primary Peritoneal Cancers

There are challenges to conducting rare cancer clinical trials due to issues surrounding clinical trial design, patient recruitment, and analysis of the study outcomes. This article highlights the challenges of research and data analysis...

Participation in Cancer Clinical Trials: Researching the Causes of Low Accrual

Achieving optimal patient accrual numbers for adult oncology clinical trials has been an ongoing problem in cancer care. As advanced practitioners (APs), some of our patients are enrolled in trials, but the number is not as high as we wo...

An Introduction to Survival Statistics: Kaplan-Meier Analysis

Innovations in Cancer Therapies and Rising Costs

Value and Financial Toxicity of New Cancer Drugs

Abstracts From JADPRO Live 2020

The posters for the abstracts below can be found at eventscribe.com/2020/jadprolive/posters/posterWall.asp

JADPRO Live 2019: Practice Innovation

In this special issue to JADPRO, we showcase select educational sessions from our annual meeting.  

Abstracts from JADPRO Live 2019

Abstracts from JADPRO Live 2019 Washington State Convention Center • Seattle • October 24–27 The posters for the abstracts below can be found at: eventscribe.com/2019/posters/JADPROLIVE/home.asp.

Abstracts from JADPRO Live 2018

Abstracts from JADPRO Live 2018 THE DIPLOMAT HOTEL, HOLLYWOOD, FLORIDA • NOVEMBER 1–4, 2018 The posters for the abstracts below can be found at eventscribe.com/2018/posters/JADPROLIVE/home.asp.

An Oncology NP-MD Partnership: Challenges and Rewards

Abstract The State of Cancer Care in America report shines a spotlight on the significant increase of cancer survivors by 2026. One strategy to help care for the increased number of patients that require ongoing care is to hire more adv...

JADPRO Live at APSHO 2017: Precision Thinking, Practical Knowledge

Oncology Nurse Practitioner Web Education Resource (ONc-PoWER): An Evaluation of a Web-Enhanced Education Resource for Nurse Practitioners Who Are New to Cancer Care

The nurse practitioner (NP) new to an advanced role in a specialty practice may find the orientation period challenging while expanding his or her professional knowledge base. The Oncology Nurse Practitioner Web Education Resource (ONc-P...

The Oncology Care Model for Advanced Practitioners

Priming the Pump: Preparing the Advanced Practitioner in Oncology for Scientific Innovation

The Wounded Healer

Starting an Advanced Practice Provider Professional Writing Group

Establishing an Individual Writing Practice

Do you have a topic in mind for a manuscript but can’t find the time or motivation to write it? This article provides step-by-step directions to encourage you to prioritize and plan your writing schedule. 

JADPRO Live at APSHO 2016: United in Practice, United in Care

Barriers to Practice and the Impact on Health Care: A Nurse Practitioner Focus

Reflections on a Name

A Conversation With Lucy Kalanithi

Recognizing the Contributions of Advanced Practitioners to Oncology Care: Are Current Metrics Enough?

Appraising Travelbee’s Human-to-Human Relationship Model

Cancer Care in 2016: The ASCO State of Cancer Care Report and the Role of Advanced Practitioners

Experiences of Nurse Practitioners in Communicating Bad News to Cancer Patients

How oncology practitioners communicate with patients has a strong impact on quality health care. Good communication facilitates positive experiences for both practitioners and patients alike, yet many practitioners report they are inadeq...

Optimizing the Teachable Moment for Health Promotion for Cancer Survivors and Their Families

JADPRO Live at APSHO 2015: Focus on Education and Collaboration

Applying Metrics to Outpatient Oncology Advanced Practice Providers

At the Abramson Cancer Center (ACC) of the University of Pennsylvania, 83% of the MDs collaborate with an advanced practice provider (APP). With the widening gap between the demand for oncology services and providers, it is estimated tha...